Ameritas Investment Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Buy |
19,524
+476
| +2% | +$33.3K | 0.04% | 502 |
|
|
2025
Q1 | $1.4M | Buy |
19,048
+522
| +3% | +$38.4K | 0.05% | 478 |
|
|
2024
Q4 | $1.21M | Buy |
18,526
+1,004
| +6% | +$65.8K | 0.04% | 558 |
|
|
2024
Q3 | $1.37M | Buy |
17,522
+633
| +4% | +$49.3K | 0.04% | 513 |
|
|
2024
Q2 | $1.32M | Hold |
16,889
| – | – | 0.05% | 503 |
|
|
2024
Q1 | $1.14M | Hold |
16,889
| – | – | 0.04% | 582 |
|
|
2023
Q4 | $1.14M | Buy |
16,889
+760
| +5% | +$51.2K | 0.04% | 564 |
|
|
2023
Q3 | $1.09M | Buy |
16,129
+3,283
| +26% | +$222K | 0.04% | 524 |
|
|
2023
Q2 | $919K | Sell |
12,846
-67
| -0.5% | -$4.8K | 0.03% | 616 |
|
|
2023
Q1 | $896K | Sell |
12,913
-72
| -0.6% | -$5K | 0.04% | 616 |
|
|
2022
Q4 | $878K | Sell |
12,985
-138
| -1% | -$9.33K | 0.04% | 638 |
|
|
2022
Q3 | $719K | Buy |
13,123
+409
| +3% | +$22.4K | 0.03% | 638 |
|
|
2022
Q2 | $840K | Buy |
12,714
+213
| +2% | +$14.1K | 0.04% | 606 |
|
|
2022
Q1 | $829K | Buy |
12,501
+12,462
| +31,954% | +$826K | 0.03% | 673 |
|
|
2021
Q4 | $2K | Hold |
39
| – | – | ﹤0.01% | 3091 |
|
|
2021
Q3 | $2K | Hold |
39
| – | – | ﹤0.01% | 3073 |
|
|
2021
Q2 | $2K | Buy |
+39
| New | +$2K | ﹤0.01% | 3029 |
|